Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China

BackgroundThe National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the i...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yulu Zhu, Jiazhen Zhu, Xingyuan Gao, Yi Sun, Hongyu Yan, Wenmin Du, Ying Wang, Xin Li
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2025-11-01
Serie:	Frontiers in Public Health
Soggetti:	National Drug Price Negotiation biopharmaceutical industry innovation performance policy evaluation difference-in-differences (DID)
Accesso online:	https://www.frontiersin.org/articles/10.3389/fpubh.2025.1705030/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!